Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor

Brain Research

Volumn 835, Issue 2, 1999, Pages 224-228

  Hjorth, Stephan ^a   Auerbach, Sidney B ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antidepressant; Autoreceptor sensitivity; Chronic citalopram treatment; Dorsal hippocampus; Frontal cortex; In vivo microdialysis; Serotonin (5 HT, 5 hydroxytryptamine)

Indexed keywords

ANTIDEPRESSANT AGENT; AUTORECEPTOR; CITALOPRAM; PENBUTOLOL; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AUTORECEPTORS; CITALOPRAM; MALE; MICRODIALYSIS; PENBUTOLOL; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0033600509     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01585-1     Document Type: Article

References (33)

1. 1A receptor antagonists increase the activity of serotonergic cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;157-165.
2. 1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;630-640.
3. Auerbach S.B., Hjorth S. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;597-606.
4. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179:1978;641-668.
5. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
6. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology. 117:1995;358-363.
7. Carlsson A., Lindqvist M. Effects of antidepressant agents on the synthesis of brain monoamines. J. Neural Transm. 43:1978;73-91.
8. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;342-348.
9. Chaput Y., de Montigny C., Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology. 5:1991;219-229.
10. Cremers T.I.F.H., De Boer P., Westerink B.H.C., Wikstrom H. Relevance of SSRI plasma concentration in relation to apparent serotonergic autoreceptor activation and chronic treatment regimens. Soc. Neurosci. Abstr. 24:1998;1112.
11. de Montigny C., Chaput Y., Blier P. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J. Clin. Psychiatry. 51:1990;4-8. Suppl. B.
12. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther. 278:1996;752-762.
13. 1A autoreceptors. Anxiety. 2:1996;149-152.
14. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1995;1064-1070.
15. Gundlah C., Hjorth S., Auerbach S.B. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology. 36:1997;475-482.
16. 1A receptor regulation - effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 4:1991;131-144.
17. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo - a microdialysis study. J. Neurochem. 60:1993;776-779.
18. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260:1994;251-255.
19. 1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology. 33:1994;331-334.
20. 1A receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-HT in vivo. Eur. J. Pharmacol. 316:1996;43-47.
21. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265:1993;707-712.
22. Hyttel J., Fredriksen-Overø K., Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology. 83:1984;20-27.
23. 1A receptors. Eur. J. Pharmacol. 260:1994;243-246.
24. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther. 268:1994;1432-1443.
25. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;141-148.
26. Levine E.S., Jacobs B.L. Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J. Neurosci. 12:1992;4037-4044.
27. McQuade R., Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem. 69:1997;791-796.
28. 1A agonists. Mol. Pharmacol. 37:1990;231-237.
29. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, CA, 1986.
30. Rutter J.J., Gundlah C., Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171:1994;183-186.
31. Rutter J.J., Gundlah C., Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse. 20:1995;225-233.
32. Sheard M.H., Zolovick A., Aghajanian G.K. Raphe neurons: Effect of tricyclic antidepressant drugs. Brain Res. 43:1972;690-694.
33. Zanardi R., Artigas F., Franchini L., Sforzini L., Gasperini M., Smeraldi E., Perez J. How long should pindolol be associated with paroxetine to improve the antidepressant response? J. Clin. Psychopharmacol. 17:1997;446-450.